Evidence map›Paper›PMID 39680483›Full record

ReviewJournal of neurochemistry2025

(Re)building the nervous system: A review of neuron-glia interactions from development to disease.

Matthew D Demmings, Luana da Silva Chagas, Marianela E Traetta, Rui S Rodrigues, Maria Florencia Acutain, Evgeny Barykin, Ashok Kumar Datusalia, Liliana German-Castelan, Vanesa S Mattera, Pedzisai Mazengenya and 2 more

Abstract readReview
In one paragraph

Review in Journal of neurochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. The role of type I collagen in white matter injury.Anatomical science international · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Glial overexpression of carbonic anhydrasemicroPublication biology · 2026
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Matthew D DemmingsNeuroscience Program, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.ORCID 0000-0001-9382-089X
Luana da Silva ChagasDepartment of Neurobiology and Program of Neurosciences, Institute of Biology, Fluminense Federal University, Niterói, Rio de Janeiro, Brazil.ORCID 0000-0002-0363-010X
Marianela E TraettaInstituto de Biología Celular y Neurociencia (IBCN), Facultad de Medicina, Conicet, Buenos Aires, Argentina.ORCID 0009-0007-1657-709X
Rui S RodriguesUniversity of Bordeaux, INSERM, Neurocentre Magendie U1215, Bordeaux, France.ORCID 0000-0002-9343-745X
Maria Florencia AcutainInstituto de Biología Celular y Neurociencia (IBCN), Facultad de Medicina, Conicet, Buenos Aires, Argentina.ORCID 0009-0005-8625-9391
Evgeny BarykinEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.ORCID 0000-0002-1292-3844
Ashok Kumar DatusaliaDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER Raebareli), Raebareli, UP, India.ORCID 0000-0002-7499-1658
Liliana German-CastelanNeuroscience Program, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.ORCID 0000-0001-6701-1917
Vanesa S MatteraInstituto de Química y Fisicoquímica Biológica (IQUIFIB-FFyB-UBA), Universidad de Buenos Aires, Buenos Aires, Argentina.ORCID 0000-0003-0600-7804
Pedzisai MazengenyaCenter of Medical and bio-Allied Health Sciences Research, College of Medicine, Ajman University, Ajman, United Arab Emirates.ORCID 0000-0003-4733-1563
Cecilia SkougDepartment of Neuroscience, Physiology & Pharmacology, Centre for Cardiovascular and Metabolic Neuroscience, University College London, London, UK.ORCID 0000-0002-4999-1939
Hisashi UmemoriDepartment of Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-7198-2062

Funding

Mechanisms of Activity-dependent Microglia-neuron Interactions in Development and DiseaseRF1NS092578 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI STEVENS, BETH ANN, UMEMORI, HISASHI · 2021 to 2023
$3.5M
NINDS NIH HHS RF1 NS092578
6 · The paper itself

Abstract

Neuron-glia interactions are fundamental to the development and function of the nervous system. During development, glia, including astrocytes, microglia, and oligodendrocytes, influence neuronal differentiation and migration, synapse formation and refinement, and myelination. In the mature brain, glia are crucial for maintaining neural homeostasis, modulating synaptic activity, and supporting metabolic functions. Neurons, inherently vulnerable to various stressors, rely on glia for protection and repair. However, glia, in their reactive state, can also promote neuronal damage, which contributes to neurodegenerative and neuropsychiatric diseases. Understanding the dual role of glia-as both protectors and potential aggressors-sheds light on their complex contributions to disease etiology and pathology. By appropriately modulating glial activity, it may be possible to mitigate neurodegeneration and restore neuronal function. In this review, which originated from the International Society for Neurochemistry (ISN) Advanced School in 2019 held in Montreal, Canada, we first describe the critical importance of glia in the development and maintenance of a healthy nervous system as well as their contributions to neuronal damage and neurological disorders. We then discuss potential strategies to modulate glial activity during disease to protect and promote a properly functioning nervous system. We propose that targeting glial cells presents a promising therapeutic avenue for rebuilding the nervous system.

Indexed as

NeurogliaNeuronsAnimalsCell CommunicationHumansNeurodegenerative Diseasesastrocytebrain development and functionglial dysfunctionmicroglianeurodegenerative and neuropsychiatric disordersoligodendrocyte

Identifiers

PMID39680483
PMCPMC11649038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.